Zuckerman Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610K | Hold |
36,406
| – | – | 0.06% | 99 |
|
|
2025
Q1 | $560K | Hold |
36,406
| – | – | 0.06% | 107 |
|
|
2024
Q4 | $632K | Buy |
36,406
+5,000
| +16% | +$86.8K | 0.06% | 99 |
|
|
2024
Q3 | $566K | Hold |
31,406
| – | – | 0.06% | 99 |
|
|
2024
Q2 | $510K | Sell |
31,406
-10,000
| -24% | -$163K | 0.06% | 96 |
|
|
2024
Q1 | $584K | Buy |
+41,406
| New | +$584K | 0.07% | 88 |
|
|
2023
Q1 | – | Sell |
-56,406
| Closed | -$514K | – | 133 |
|
|
2022
Q4 | $514K | Buy |
+56,406
| New | +$514K | 0.08% | 81 |
|
|
2022
Q3 | – | Sell |
-20,000
| Closed | -$150K | – | 123 |
|
|
2022
Q2 | $150K | Hold |
20,000
| – | – | 0.03% | 104 |
|
|
2022
Q1 | $188K | Buy |
+20,000
| New | +$188K | 0.03% | 105 |
|
|
2021
Q2 | – | Sell |
-21,406
| Closed | -$247K | – | 118 |
|
|
2021
Q1 | $247K | Hold |
21,406
| – | – | 0.04% | 98 |
|
|
2020
Q4 | $207K | Hold |
21,406
| – | – | 0.04% | 84 |
|
|
2020
Q3 | $193K | Hold |
21,406
| – | – | 0.04% | 75 |
|
|
2020
Q2 | $264K | Hold |
21,406
| – | – | 0.06% | 68 |
|
|
2020
Q1 | $192K | Buy |
+21,406
| New | +$192K | 0.06% | 66 |
|
|
2019
Q4 | – | Sell |
-10,406
| Closed | -$72K | – | 71 |
|
|
2019
Q3 | $72K | Hold |
10,406
| – | – | 0.02% | 65 |
|
|
2019
Q2 | $96K | Buy |
+10,406
| New | +$96K | 0.02% | 64 |
|